The GcMAF Story
GcMAF was first researched and identified by Nobuto Yamamoto in 1991. Since then, it has been the subject of numerous clinical trials worldwide, and has been approved as a food or supplement in several countries. GcMAF is derived from a vitamin D-binding protein, which when modified, may activate macrophages, a type of white blood cell.
Endorsed by Medical Experts
Our products are supported by the expertise of the world's leading experts in GcMAF research, development and use. The MAF Supplies range draw on the work of a number of medical pioneers.